COVID-19 Impact on Global Addictions Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: CB08D226D3E7EN
QYResearch

Abstracts

This report focuses on the global Addictions Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Addictions Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Alkermes Plc
• Amneal Pharmaceuticals Inc.
• Indivior Plc
• Johnson & Johnson Services Inc.
• Mylan NV
• Novartis AG
• Novo Nordisk AS
• Opiant Pharmaceuticals Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.

Market segment by Type, the product can be split into

• Alcohol Addiction Therapeutics
• Tobacco Addiction Therapeutics
• Drug Addiction Therapeutics

Market segment by Application, split into

• Public
• Private
• Government

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Addictions Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Addictions Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Addictions Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Addictions Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Addictions Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Alcohol Addiction Therapeutics
  1.4.3 Tobacco Addiction Therapeutics
  1.4.4 Drug Addiction Therapeutics
1.5 Market by Application
  1.5.1 Global Addictions Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Public
  1.5.3 Private
  1.5.4 Government
1.6 Coronavirus Disease 2019 (Covid-19): Addictions Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Addictions Therapeutics Industry
    1.6.1.1 Addictions Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Addictions Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Addictions Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Addictions Therapeutics Market Perspective (2015-2026)
2.2 Addictions Therapeutics Growth Trends by Regions
  2.2.1 Addictions Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Addictions Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Addictions Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Addictions Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Addictions Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Addictions Therapeutics Players by Market Size
  3.1.1 Global Top Addictions Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Addictions Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Addictions Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Addictions Therapeutics Market Concentration Ratio
  3.2.1 Global Addictions Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Addictions Therapeutics Revenue in 2019
3.3 Addictions Therapeutics Key Players Head office and Area Served
3.4 Key Players Addictions Therapeutics Product Solution and Service
3.5 Date of Enter into Addictions Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Addictions Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Addictions Therapeutics Forecasted Market Size by Type (2021-2026)

5 ADDICTIONS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Addictions Therapeutics Market Size by Application (2015-2020)
5.2 Global Addictions Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Addictions Therapeutics Market Size (2015-2020)
6.2 Addictions Therapeutics Key Players in North America (2019-2020)
6.3 North America Addictions Therapeutics Market Size by Type (2015-2020)
6.4 North America Addictions Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Addictions Therapeutics Market Size (2015-2020)
7.2 Addictions Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Addictions Therapeutics Market Size by Type (2015-2020)
7.4 Europe Addictions Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Addictions Therapeutics Market Size (2015-2020)
8.2 Addictions Therapeutics Key Players in China (2019-2020)
8.3 China Addictions Therapeutics Market Size by Type (2015-2020)
8.4 China Addictions Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Addictions Therapeutics Market Size (2015-2020)
9.2 Addictions Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Addictions Therapeutics Market Size by Type (2015-2020)
9.4 Japan Addictions Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Addictions Therapeutics Market Size (2015-2020)
10.2 Addictions Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Addictions Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Addictions Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Addictions Therapeutics Market Size (2015-2020)
11.2 Addictions Therapeutics Key Players in India (2019-2020)
11.3 India Addictions Therapeutics Market Size by Type (2015-2020)
11.4 India Addictions Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Addictions Therapeutics Market Size (2015-2020)
12.2 Addictions Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Addictions Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Addictions Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Alkermes Plc
  13.1.1 Alkermes Plc Company Details
  13.1.2 Alkermes Plc Business Overview and Its Total Revenue
  13.1.3 Alkermes Plc Addictions Therapeutics Introduction
  13.1.4 Alkermes Plc Revenue in Addictions Therapeutics Business (2015-2020))
  13.1.5 Alkermes Plc Recent Development
13.2 Amneal Pharmaceuticals Inc.
  13.2.1 Amneal Pharmaceuticals Inc. Company Details
  13.2.2 Amneal Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Introduction
  13.2.4 Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2015-2020)
  13.2.5 Amneal Pharmaceuticals Inc. Recent Development
13.3 Indivior Plc
  13.3.1 Indivior Plc Company Details
  13.3.2 Indivior Plc Business Overview and Its Total Revenue
  13.3.3 Indivior Plc Addictions Therapeutics Introduction
  13.3.4 Indivior Plc Revenue in Addictions Therapeutics Business (2015-2020)
  13.3.5 Indivior Plc Recent Development
13.4 Johnson & Johnson Services Inc.
  13.4.1 Johnson & Johnson Services Inc. Company Details
  13.4.2 Johnson & Johnson Services Inc. Business Overview and Its Total Revenue
  13.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Introduction
  13.4.4 Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2015-2020)
  13.4.5 Johnson & Johnson Services Inc. Recent Development
13.5 Mylan NV
  13.5.1 Mylan NV Company Details
  13.5.2 Mylan NV Business Overview and Its Total Revenue
  13.5.3 Mylan NV Addictions Therapeutics Introduction
  13.5.4 Mylan NV Revenue in Addictions Therapeutics Business (2015-2020)
  13.5.5 Mylan NV Recent Development
13.6 Novartis AG
  13.6.1 Novartis AG Company Details
  13.6.2 Novartis AG Business Overview and Its Total Revenue
  13.6.3 Novartis AG Addictions Therapeutics Introduction
  13.6.4 Novartis AG Revenue in Addictions Therapeutics Business (2015-2020)
  13.6.5 Novartis AG Recent Development
13.7 Novo Nordisk AS
  13.7.1 Novo Nordisk AS Company Details
  13.7.2 Novo Nordisk AS Business Overview and Its Total Revenue
  13.7.3 Novo Nordisk AS Addictions Therapeutics Introduction
  13.7.4 Novo Nordisk AS Revenue in Addictions Therapeutics Business (2015-2020)
  13.7.5 Novo Nordisk AS Recent Development
13.8 Opiant Pharmaceuticals Inc.
  13.8.1 Opiant Pharmaceuticals Inc. Company Details
  13.8.2 Opiant Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Introduction
  13.8.4 Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2015-2020)
  13.8.5 Opiant Pharmaceuticals Inc. Recent Development
13.9 Pfizer Inc.
  13.9.1 Pfizer Inc. Company Details
  13.9.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.9.3 Pfizer Inc. Addictions Therapeutics Introduction
  13.9.4 Pfizer Inc. Revenue in Addictions Therapeutics Business (2015-2020)
  13.9.5 Pfizer Inc. Recent Development
13.10 Teva Pharmaceutical Industries Ltd.
  13.10.1 Teva Pharmaceutical Industries Ltd. Company Details
  13.10.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
  13.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Introduction
  13.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2015-2020)
  13.10.5 Teva Pharmaceutical Industries Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Addictions Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Addictions Therapeutics Revenue
Table 3. Ranking of Global Top Addictions Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Addictions Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Alcohol Addiction Therapeutics
Table 6. Key Players of Tobacco Addiction Therapeutics
Table 7. Key Players of Drug Addiction Therapeutics
Table 8. COVID-19 Impact Global Market: (Four Addictions Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Addictions Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Addictions Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Addictions Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Addictions Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Addictions Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Addictions Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Addictions Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Addictions Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Addictions Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Addictions Therapeutics Players
Table 24. Global Addictions Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Addictions Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Addictions Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addictions Therapeutics as of 2019)
Table 27. Global Addictions Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Addictions Therapeutics Product Solution and Service
Table 30. Date of Enter into Addictions Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Addictions Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Addictions Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Addictions Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Addictions Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Addictions Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Addictions Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Addictions Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Addictions Therapeutics Market Share (2019-2020)
Table 40. North America Addictions Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Addictions Therapeutics Market Share by Type (2015-2020)
Table 42. North America Addictions Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Addictions Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Addictions Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Addictions Therapeutics Market Share (2019-2020)
Table 46. Europe Addictions Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Addictions Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Addictions Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Addictions Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Addictions Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Addictions Therapeutics Market Share (2019-2020)
Table 52. China Addictions Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Addictions Therapeutics Market Share by Type (2015-2020)
Table 54. China Addictions Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Addictions Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Addictions Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Addictions Therapeutics Market Share (2019-2020)
Table 58. Japan Addictions Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Addictions Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Addictions Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Addictions Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Addictions Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Addictions Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Addictions Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Addictions Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Addictions Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Addictions Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Addictions Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Addictions Therapeutics Market Share (2019-2020)
Table 70. India Addictions Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Addictions Therapeutics Market Share by Type (2015-2020)
Table 72. India Addictions Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Addictions Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Addictions Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Addictions Therapeutics Market Share (2019-2020)
Table 76. Central & South America Addictions Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Addictions Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Addictions Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Addictions Therapeutics Market Share by Application (2015-2020)
Table 80. Alkermes Plc Company Details
Table 81. Alkermes Plc Business Overview
Table 82. Alkermes Plc Product
Table 83. Alkermes Plc Revenue in Addictions Therapeutics Business (2015-2020) (Million US$)
Table 84. Alkermes Plc Recent Development
Table 85. Amneal Pharmaceuticals Inc. Company Details
Table 86. Amneal Pharmaceuticals Inc. Business Overview
Table 87. Amneal Pharmaceuticals Inc. Product
Table 88. Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2015-2020) (Million US$)
Table 89. Amneal Pharmaceuticals Inc. Recent Development
Table 90. Indivior Plc Company Details
Table 91. Indivior Plc Business Overview
Table 92. Indivior Plc Product
Table 93. Indivior Plc Revenue in Addictions Therapeutics Business (2015-2020) (Million US$)
Table 94. Indivior Plc Recent Development
Table 95. Johnson & Johnson Services Inc. Company Details
Table 96. Johnson & Johnson Services Inc. Business Overview
Table 97. Johnson & Johnson Services Inc. Product
Table 98. Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2015-2020) (Million US$)
Table 99. Johnson & Johnson Services Inc. Recent Development
Table 100. Mylan NV Company Details
Table 101. Mylan NV Business Overview
Table 102. Mylan NV Product
Table 103. Mylan NV Revenue in Addictions Therapeutics Business (2015-2020) (Million US$)
Table 104. Mylan NV Recent Development
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Product
Table 108. Novartis AG Revenue in Addictions Therapeutics Business (2015-2020) (Million US$)
Table 109. Novartis AG Recent Development
Table 110. Novo Nordisk AS Company Details
Table 111. Novo Nordisk AS Business Overview
Table 112. Novo Nordisk AS Product
Table 113. Novo Nordisk AS Revenue in Addictions Therapeutics Business (2015-2020) (Million US$)
Table 114. Novo Nordisk AS Recent Development
Table 115. Opiant Pharmaceuticals Inc. Business Overview
Table 116. Opiant Pharmaceuticals Inc. Product
Table 117. Opiant Pharmaceuticals Inc. Company Details
Table 118. Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2015-2020) (Million US$)
Table 119. Opiant Pharmaceuticals Inc. Recent Development
Table 120. Pfizer Inc. Company Details
Table 121. Pfizer Inc. Business Overview
Table 122. Pfizer Inc. Product
Table 123. Pfizer Inc. Revenue in Addictions Therapeutics Business (2015-2020) (Million US$)
Table 124. Pfizer Inc. Recent Development
Table 125. Teva Pharmaceutical Industries Ltd. Company Details
Table 126. Teva Pharmaceutical Industries Ltd. Business Overview
Table 127. Teva Pharmaceutical Industries Ltd. Product
Table 128. Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2015-2020) (Million US$)
Table 129. Teva Pharmaceutical Industries Ltd. Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Addictions Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Alcohol Addiction Therapeutics Features
Figure 3. Tobacco Addiction Therapeutics Features
Figure 4. Drug Addiction Therapeutics Features
Figure 5. Global Addictions Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Public Case Studies
Figure 7. Private Case Studies
Figure 8. Government Case Studies
Figure 9. Addictions Therapeutics Report Years Considered
Figure 10. Global Addictions Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Addictions Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Addictions Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Addictions Therapeutics Market Share by Players in 2019
Figure 15. Global Top Addictions Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addictions Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Addictions Therapeutics Revenue in 2019
Figure 17. North America Addictions Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Addictions Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Addictions Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Addictions Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Addictions Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Addictions Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Addictions Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Alkermes Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Alkermes Plc Revenue Growth Rate in Addictions Therapeutics Business (2015-2020)
Figure 26. Amneal Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Amneal Pharmaceuticals Inc. Revenue Growth Rate in Addictions Therapeutics Business (2015-2020)
Figure 28. Indivior Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Indivior Plc Revenue Growth Rate in Addictions Therapeutics Business (2015-2020)
Figure 30. Johnson & Johnson Services Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Johnson & Johnson Services Inc. Revenue Growth Rate in Addictions Therapeutics Business (2015-2020)
Figure 32. Mylan NV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Mylan NV Revenue Growth Rate in Addictions Therapeutics Business (2015-2020)
Figure 34. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Novartis AG Revenue Growth Rate in Addictions Therapeutics Business (2015-2020)
Figure 36. Novo Nordisk AS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novo Nordisk AS Revenue Growth Rate in Addictions Therapeutics Business (2015-2020)
Figure 38. Opiant Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Opiant Pharmaceuticals Inc. Revenue Growth Rate in Addictions Therapeutics Business (2015-2020)
Figure 40. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Pfizer Inc. Revenue Growth Rate in Addictions Therapeutics Business (2015-2020)
Figure 42. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Addictions Therapeutics Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed